HomeInsightsShare Holding

Dr Reddys Laboratories Ltd Share Holding Pattern

Dr Reddys Laboratories Ltd Share Holding Pattern

stocks purchased

₹ 7.8 Cr

Volume Transacted

(Nov 21, 2024)

stocks purchased

64.9 K

Stocks Traded

(Nov 21, 2024)

Last Updated on: Nov 21, 2024

Promoters Holdings Over Time

Key Highlights

  • Mutual funds increased their stake in the company by 2.10% from March 2024 to June 2024.
  • Promoters decreased their stake in the company by 0.00% from March 2024 to June 2024. FIIs/FPIs decreased their stake in the company by 1.46% from March 2024 to June 2024.

Latest Shareholding

Market Price of Dr Reddys Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Dr Reddys Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 20241194.55
19 Nov 20241213.95
18 Nov 20241193.35
14 Nov 20241226.05
13 Nov 20241245.7
12 Nov 20241263.1
11 Nov 20241288.2
08 Nov 20241281.85
07 Nov 20241287.15
06 Nov 20241303

Dr Reddys Laboratories Ltd News Hub

News

DRL slips after Hyderabad facility gets 7 observations from USFDA

The GMP inspection was conducted from 13 November 2024 to 19 November 2024. The USFDA issu...

Read more

21 Nov 202410:23

News

DRL's Hyderabad facility gets 7 observations from USFDA

The GMP inspection was conducted from 13 November 2024 to 19 November 2024. The USFDA issu...

Read more

20 Nov 202410:40

News

Mexican health regulator imposes penalty on Dr Reddy's

Dr Reddys Laboratories has received an order dated 12 November 2024, from COFEPRIS (Comisi...

Read more

14 Nov 202409:22

News

Dr Reddys Laboratories Ltd spurts 2.25%

Dr Reddys Laboratories Ltd is up for a third straight session in a row. The stock is quoti...

Read more

06 Nov 202413:05

News

Dr Reddy's Q2 PAT slides 15% YoY to Rs 1,255 crore

Total revenue from operations stood at Rs 8,038.2 crore in Q2 FY25, up 16.45% YoY, primari...

Read more

05 Nov 202417:35

News

Aurigene Oncology receives nod for Phase 2 clinical trial for Ribrecabtagene autoleucel

Aurigene Oncology, a wholly-owned subsidiary of Dr. Reddy's Laboratories has announced the...

Read more

08 Oct 202418:16

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Aug 2024

Transcript

July 2024

Transcript

May 2024

Transcript

Feb 2024

Transcript

Nov 2023

Transcript

July 2023

TranscriptPPT

May 2023

Transcript

Jan 2023

Transcript

Nov 2022

Transcript

June 2022

TranscriptPPT

Feb 2022

Transcript

Nov 2021

Transcript

Aug 2021

Transcript

May 2021

Transcript

May 2020

Transcript

Jan 2020

Transcript

FAQs for EPS of Dr Reddys Laboratories Ltd

On what factors does the shareholding pattern of Dr Reddys Laboratories Ltd change frequently?

The shareholding pattern of Dr Reddys Laboratories Ltd can change due to various factors such as stock market transactions, new share issuances, buy-backs, or changes in ownership by institutional and retail investors.

How often is Dr Reddys Laboratories Ltd's shareholding pattern updated?

The Dr Reddys Laboratories Ltd shareholding pattern is typically updated quarterly or semi-annually, depending on regulatory requirements and internal reporting schedules.

What categories are included in the shareholding pattern of Dr Reddys Laboratories Ltd?

Categories included in the shareholding pattern of Dr Reddys Laboratories Ltd include promoter/management holdings, institutional investors, retail investors, and others such as foreign investors.

Why is the shareholding pattern of Dr Reddys Laboratories Ltd important for investors?

The shareholding pattern of Dr Reddys Laboratories Ltd is important for investors as it provides insights into ownership distribution, control dynamics, and the potential influence of major shareholders on company decisions and stock performance.

Where can I find the latest shareholding pattern of Dr Reddys Laboratories Ltd?

The latest shareholding pattern of Dr Reddys Laboratories Ltd can be found on BlinkX. You may also check the quarterly financial reports, which are available on the company’s official website under the Investor Relations section. Additionally, you can check stock exchange websites like NSE and BSE for the most recent filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*